Related Experiment Videos
Progressive multifocal leuco-encephalopathy
Abstract:
Progressive multifocal leuco-encephalopathy (PML) is a demyelinating viral infection of the central nervous system, usually fatal and characterized by widespread lesions mainly in the cerebral hemisphere. PML is a disease of adult life, usually occurring in a setting of chronic neoplastic disease and less often non-neoplastic granulomatous disease. The disorder usually evolves rapidly. Of all laboratory investigations electro-encephalography is the most useful for indicating the severity of pathological involvement. PML is believed to result from infection with papovaviruses, an SV40-like agent and a JC virus. Both viruses are oncogenic in hamsters. There is no effective therapy.
Insights
Progressive multifocal leukoencephalopathy (PML) is a fatal central nervous system viral infection causing widespread brain lesions. Currently, no effective therapy exists for this rapidly evolving neurological disorder.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease of the central nervous system.
- PML typically affects adults with compromised immune systems, often due to chronic neoplastic or granulomatous diseases.
- The condition is characterized by rapid neurological decline and widespread lesions in the cerebral hemisphere.
Purpose of the Study:
- To provide a comprehensive overview of Progressive Multifocal Leukoencephalopathy (PML).
- To discuss the etiology, clinical presentation, diagnostic indicators, and current therapeutic limitations of PML.
Main Methods:
- Review of existing literature on PML.
- Analysis of clinical and pathological findings associated with PML.
- Discussion of diagnostic tools, particularly electroencephalography (EEG).
Main Results:
- PML is a severe demyelinating viral infection caused by papovaviruses, including JC virus and SV40-like agents.
- Electroencephalography (EEG) is identified as the most valuable laboratory investigation for assessing pathological involvement severity.
- The disease typically presents rapidly in immunocompromised individuals, often with a poor prognosis.
Conclusions:
- PML is a significant neurological challenge with no effective treatment options currently available.
- Understanding the viral agents and disease progression is crucial for potential future therapeutic strategies.
- Further research is needed to develop effective therapies for this devastating condition.